PKST Peakstone far outperforms Q4 2025 EPS expectations as shares tick modestly higher in todays trading SYRE Spyre Therapeutics reports narrower Q4 2025 pershare loss than consensus forecasts with shares edging higher in todays trading BOOT Boot Barn Q1 2026 EPS tops estimates by 6 percent shares climb 337 percent on upbeat investor reaction What is impacting BioHarvest BHST stock performance Q1 2025 Profit Disappoints LaFayette LAFAR Stock Is It Forming a Pattern